💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

European shares end marginally lower on tech drag; Fed in focus

Published 09/16/2024, 03:24 AM
Updated 09/16/2024, 12:32 PM
© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, September 12, 2024.  REUTERS/Staff/File Photo
STOXX
-

By Shubham Batra and Shashwat Chauhan

(Reuters) -Europe's STOXX 600 closed slightly lower on Monday as losses in heavyweight technology shares weighed on the index, while the focus remained on the U.S. Federal Reserve, which is widely expected to kick off its policy easing cycle this week.

The pan-European STOXX 600 index ended 0.2% lower, snapping a three-day winning streak.

Europe's tech index dipped 1.2%, the biggest percentage decliner amongst major STOXX sectors, following its near 5% jump last week.

Retail led advances with an 0.9% rise, boosted by a 3.1% increase in H&M (ST:HMb).

All eyes will be on the U.S. central bank's interest rate decision on Wednesday, with money markets pencilling in a 61% chance of a 50-basis-point rate cut, and a total easing of 120 bps in 2024.

"With the Fed set to hop aboard the (rate-cut) bandwagon, a global easing cycle should be a tailwind for equities after the European Central Bank opted to cut rates for the second time in three months," wrote analysts at Glenmede led by Jason Pride, chief of investment strategy & research.

"Momentum behind global easing cycles has historically been a bullish signal for equities in the short-to-medium term."

Central bank rate decisions in Norway and the UK will also be on investors' radar this week.

The ECB's chief economist Philip Lane said the bank should keep cutting interest rates gradually, but its policymakers expressed differing views on how to signal their intent given economic uncertainty.

Among individual movers, France's Rexel jumped 9.1% after the Paris-listed group rebuffed an around $9.4 billion acquisition offer from billionaire Brad Jacobs-led QXO.

French drugmaker Ipsen rose 3.7% after RBC raised its rating to "outperform" from "sector perform", seeing mid-term support from its liver disease drug Iqirvo (PBC) after its U.S. FDA approval in June.

On the flip side, shares of Nestle weighed on the benchmark index with a 1% fall after Morgan Stanley cut the stock's rating to "underweight" and reduced its target price.

© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, September 12, 2024.  REUTERS/Staff/File Photo

France's Worldline slumped 15.2%, extending losses from Friday when the payments group said its long-time CEO Gilles Grapinet would leave the company as it issued its third profit warning.

Phoenix Group shed 5.3% after the British insurer halted the sale process of its SunLife business due to market uncertainty.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.